Biohaven - Stock Split History | BHVN
Stock split history for Biohaven since 2023. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| Biohaven Annual Stock Splits |
|---|
| Biohaven Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Biomedical and Genetics | $1.264B | $0.463B |
| Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | United States | $155.188B | 9.47 |
| GSK (GSK) | United Kingdom | $72.345B | 9.01 |
| Bio-Rad Laboratories (BIO.B) | United States | $12.069B | 28.64 |
| QIAGEN (QGEN) | Netherlands | $11.333B | 19.34 |
| Ginkgo Bioworks Holdings (DNA) | United States | $3.395B | 0.00 |
| Myovant Sciences (MYOV) | United Kingdom | $2.604B | 0.00 |
| Arcus Biosciences (RCUS) | United States | $1.672B | 25.10 |
| Emergent Biosolutions (EBS) | United States | $0.655B | 5.15 |
| ADC Therapeutics SA (ADCT) | Switzerland | $0.363B | 0.00 |
| Ambrx Biopharma (AMAM) | United States | $0.073B | 0.00 |
| Enzo Biochem (ENZ) | United States | $0.073B | 0.00 |
| Gelesis Holdings (GLS) | United States | $0.027B | 0.00 |
| SQZ Biotechnologies (SQZ) | United States | $0.025B | 0.00 |
